Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 10, 2025

Mobicip CEO Calls on AI Developers to Include Built-In Parental Controls for Child Safety and Transparency
Suren Ramasubbu, CEO of Mobicip, urges AI companies to adopt age-aware filters, conversation logs, and parental oversight features to protect young users. CALIFORNIA, CA, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- As artificial intelligence …

Black Epic Entertainment Launches BlackEpic.org, Pioneering a Direct-to-Audience Model in Immersive Media
OAKLAND, CA, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- In a digital landscape dominated by algorithms and creative compromise, one independent studio is carving a new path. Black Epic Entertainment, the visionary media company founded by Eddie R, …

Directional Sound Technology Enhances Museum Experiences Ahead of International Museum Day
LOS ANGELES, CA, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- As museums around the world prepare to celebrate International Museum Day on May 18, a growing number of institutions are embracing sound control technology to create more immersive, …

TravelingWiki Foundation CEO Jonathan Sutter Named as One of the Top Six Global Autism Travel Influencers
On the eve of appearing at The Rose Bowl, TravelingWiki’s CEO, Jonathan Sutter, named as one of the Top 6 Autism Travel Influencers Globally by Google. PASADENA, CA, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- On the eve of appearing at the …

Fambase Now Enables More Effective Online Teaching for Course Creators
The platform now supports feedback-driven instruction and real-time group interaction within closed teaching groups, giving instructors more control NEW YORK, NY, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- Teaching online has become a default for …

Birdfy to Showcase Smart Birding Innovation at the 2025 Biggest Week in American Birding
Birdfy debuted at Global Pet Expo with smart birdwatching tech, showcasing AI-powered feeders and nests that expand “pet” to include our wild neighbors. LOS ANGELES, CA, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- Birdfy, a leading brand in smart …

Discount Drain Cleaning® Upgrades Plumbing Services with Trenchless Technology
Discount Drain Cleaning® delivers trenchless technology and plumbing services for reliable, long-lasting sewer solutions. LAS VEGAS, NV, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- Discount Drain Cleaning®, a trusted and locally owned drain …

Akero Therapeutics présente les résultats de la 96e semaine de l’essai clinique de phase 2b SYMMETRY sur l’éfruxifermine chez des patients atteints de cirrhose compensée causée par une stéatohépatite associée à un dysfonctionnement métabolique (MASH), …
SOUTH SAN FRANCISCO, État de Californie, 10 mai 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ : AKRO), une société en phase clinique développant des traitements révolutionnaires pour les patients atteints de maladies métaboliques graves et dont …

Akero Therapeutics präsentiert auf dem EASL-Kongress 2025 die Ergebnisse nach 96 Wochen der klinischen Phase-IIb-Studie SYMMETRY zu Efruxifermin bei Patienten mit kompensierter Zirrhose, die durch MASH verursacht wird, und zeigt eine Verbesserung der…
SOUTH SAN FRANCISCO, Kalifornien, May 10, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), ein in der klinischen Phase tätiges Unternehmen, das bahnbrechende Therapien für Patienten mit schwerwiegenden Stoffwechselkrankheiten entwickelt, …

Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt
Die Ergebnisse stützen den potenziellen Nutzen von Efruxifermin (EFX) für eine Fibrosebesserung unter Patienten mit kompensierter Zirrhose (F4-Fibrose) aufgrund von MASH auf Basis von SYMMETRY-Studiendaten nach 96 Wochen, die auf dem EASL Congress 2025 …

Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine
Les résultats confirment le bénéfice potentiel de l’éfruxifermine (EFX) pour déclencher une amélioration de la fibrose chez les patients atteints de cirrhose compensée (fibrose F4) due à une MASH ; les données à 96 semaines de l’essai SYMMETRY ont fait l’ …

Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response Data contribute to growing body of support around the anti-fibrotic activity of EFX in patients with pre-cirrhotic MASH SOUTH SAN …

Jiangxi Through Its Cultural Relics: Witnesses of a Millennia-old Civilization
NANCHANG, JIANGXI, CHINA, May 10, 2025 /EINPresswire.com/ -- The Jiangxi Provincial Department of Culture and Tourism today announced a renewed effort to promote the region’s extensive cultural heritage on the international stage. Through a series of …